February 18, 2014
by Julie Deisher
The Supreme Court of Georgia heard arguments on Monday regarding the constitutionality of a law allowing the state to withhold the identities of the manufacturers of Georgia's lethal injection drugs. Last May, Georgia Governor Nathan Deal signed into law HB 122, which included a provision ...[read more]
April 11, 2013
by Endia Vereen
JURIST Guest Columnist, Daniel Perrone, St. John's University School of Law Class of 2013, discusses the implications of the US Supreme Court decision insulating generic drug manufacturers from liability against failure to warn claims...In 2011, generic drugs accounted for nearly 80 percent of the ...[read more]
December 10, 2012
by Sarah Steers
On December 10, 2010, the US Supreme Court granted certiorari in three cases involving the duty of generic drug manufacturers to supply side effect warnings on labels. The Court consolidated three cases, all involving a neurological side effect stemming from the use of the gastric reflux medicine ...[read more]
December 11, 2010
by Brian Jackson
The US Supreme Court on Friday granted certiorari in three cases related to the duty of generic drug manufacturers to list possible side effects on the labels of medicines they produce. The three cases, PLIVA Inc. v. Mensing, Actavis v. Mensing and Actavis v. Demahy were consolidated and will ...[read more]
June 12, 2009
by Christian Ehret
The US House of Representatives on Friday approved the Family Smoking Prevention and Tobacco Control Act, which attempts to safeguard the public by granting the Food and Drug Administration (FDA) certain authority to regulate tobacco products, among other provisions. Passed by a vote of 307-97, ...[read more]
October 30, 2008
by Jake Oresick
The US House Committee on Oversight and Government Reform on Wednesday issued a report revealing that top Food and Drug Administration (FDA) officials opposed FDA regulations that preempt consumersí ability to bring tort claims against drug manufacturers. The report said that career FDA officia... ...[read more]
September 11, 2008
by Devin Montgomery
Texas Attorney General Greg Abbott announced Tuesday that the state has reached a settlement in a Medicare fraud lawsuit it had brought against drug manufacturer Abbott Laboratories. In the suit, Texas had alleged that Abbott Laboratories and other drug manufacturers had inflated drug prices that... ...[read more]
May 22, 2008
by Andrew Gilmore
Drug companies are harming consumers by using pay-for-delay legal agreements to keep cheaper generic prescription drugs off the market, according to a report released Wednesday by the US Federal Trade Commission (FTC). The report compares legal documents submitted to the FTC by drug man... ...[read more]
June 25, 2007
by Gabriel Haboubi
The US Supreme Court granted certiorari Monday in four cases to be heard next term. In Riegel v. Medtronic (06-179) the court will decide whether Food and Drug Administration (FDA) regulation of medical devices protects manufacturers, such as Medtronic, Inc., from state product liability lawsuits... ...[read more]
April 13, 2007
by Stefanie Presley
The US Senate Committee on Finance has approved a bill which would provide the Secretary of the Department of Health and Human Services the authority to negotiate drug prices on behalf of Medicare beneficiaries with drug manufacturers, insurers and pharmacies. The Medicare Prescription Drug Price ...[read more]

Support JURIST

We rely on our readers to keep JURIST running

 Donate now!

© Copyright JURIST Legal News and Research Services, Inc., 2013.